Bristol-Myers Squibb (BMS) Total Revenue: $48.19B Founded Year: 1887 Total Employees: 32,500 Headquarters: New Jersey, United States Market Cap: $121.42B Stock Exchange: NYSE BMS is a global biopharma company focused on oncology, hematology, immunology, and cardiovascular diseases, with a strong portfolio of innovative therapies and a legacy of blockbuster drugs
Indication-specific advantages: Glucagon co-agonists such as survodutide, mazdutide, and retatrutide may have superior hepatic effects in MASH and MASLD because glucagon acts directly on liver lipid metabolism
Germany Off-Grid Energy Storage Market Size, Share, Trend About the Spherical Insights & Consulting Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI
Furthermore, studies such as the STEP-HFpEF trial with GLP-1 receptor agonists have shown optimized exercise capacity and reduced heart failure symptoms in patients